Abstract
Background: Nickel (Ni) is a metal largely present in the environment and prolonged exposure to it may lead to multiple pathological conditions in human subjects. Among these, the most frequent is allergic contact dermatitis.
Methods: Peripheral blood mononuclear cells isolated from 25 patients with Ni-dependent contact dermatitis were evaluated in terms of cytokine release and nitric oxide (NO) production in the presence or absence of two doses (3 and 5 µg, respectively) of polyphenols. Results: Polyphenols were able to reduce the increased release of interferon-γ and interleukin (IL)-4, while maintaining the equilibrium between IL-10 and IL-17. At the same time, exaggerated release of NO was reduced by polyphenol supplementation. Conclusion: In view of their anti-inflammatory activities, polyphenols may represent a potential therapeutic tool to treat Ni-sensitized patients.Keywords: Allergic contact dermatitis, interleukin, nickel, nitric oxide, peripheral blood mononuclear cells, polyphenols.
Graphical Abstract
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:In vitro Effects of Polyphenols on the Peripheral Immune Responses in Nickel-sensitized Patients
Volume: 17 Issue: 4
Author(s): Thea Magrone*, Paolo Romita, Pietro Verni, Rosaria Salvatore, Anna Spagnoletta, Manrico Magrone, Matteo A. Russo, Emilio Jirillo and Caterina Foti
Affiliation:
- Department of Basic Medical Sciences, Neuroscience and Sensory Organs, University of Bari, P.zza Giulio Cesare 11, 70124 Bari, Bari,Italy
Keywords: Allergic contact dermatitis, interleukin, nickel, nitric oxide, peripheral blood mononuclear cells, polyphenols.
Abstract: Background: Nickel (Ni) is a metal largely present in the environment and prolonged exposure to it may lead to multiple pathological conditions in human subjects. Among these, the most frequent is allergic contact dermatitis.
Methods: Peripheral blood mononuclear cells isolated from 25 patients with Ni-dependent contact dermatitis were evaluated in terms of cytokine release and nitric oxide (NO) production in the presence or absence of two doses (3 and 5 µg, respectively) of polyphenols. Results: Polyphenols were able to reduce the increased release of interferon-γ and interleukin (IL)-4, while maintaining the equilibrium between IL-10 and IL-17. At the same time, exaggerated release of NO was reduced by polyphenol supplementation. Conclusion: In view of their anti-inflammatory activities, polyphenols may represent a potential therapeutic tool to treat Ni-sensitized patients.Export Options
About this article
Cite this article as:
Magrone Thea*, Romita Paolo, Verni Pietro, Salvatore Rosaria, Spagnoletta Anna, Magrone Manrico, Russo A. Matteo, Jirillo Emilio and Foti Caterina, In vitro Effects of Polyphenols on the Peripheral Immune Responses in Nickel-sensitized Patients, Endocrine, Metabolic & Immune Disorders - Drug Targets 2017; 17 (4) . https://dx.doi.org/10.2174/1871530317666171003161314
DOI https://dx.doi.org/10.2174/1871530317666171003161314 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Interferon-γ-Induced Neurotoxicity of Human Astrocytes
CNS & Neurological Disorders - Drug Targets C-type Natriuretic Peptide (CNP): Cardiovascular Roles and Potential as a Therapeutic Target
Current Pharmaceutical Design Targeting Kruppel-Like Factor 5 (KLF5) for Cancer Therapy
Current Topics in Medicinal Chemistry Patent Selections:
Recent Patents on Regenerative Medicine Treatment of Nasopharyngeal Carcinoma: Therapeutic Management and Future View of Epstein-Barr Virus-Targeting Treatment
Current Cancer Therapy Reviews Placebos Used in Clinical Trials for Chinese Herbal Medicine
Recent Patents on Inflammation & Allergy Drug Discovery Diabetes and Its Complications: Therapies Available, Anticipated and Aspired
Current Diabetes Reviews β-Catenin/TCF-4 Signaling Regulates Susceptibility of Macrophages and Resistance of Monocytes to HIV-1 Productive Infection
Current HIV Research The ECL Cell: Relay Station for Gastric Integrity
Current Medicinal Chemistry Toll-like Receptor-4: A New Target for Preterm Labour Pharmacotherapies?
Current Pharmaceutical Design Hereditary Haemorrhagic Telangiectasia (HHT): Genetic and Molecular Aspects
Current Pharmaceutical Design Drug-Induced Anemia and Other Red Cell Disorders: A Guide in the Age of Polypharmacy
Current Clinical Pharmacology Basement Membrane Peptides: Functional Considerations and Biomedical Applications in Autoimmunity
Current Medicinal Chemistry Post-translational Modifications of bZIP Transcription Factors in Abscisic Acid Signaling and Drought Responses
Current Genomics Drug Induced Cutaneous Manifestations due to Treatment of Gastrointestinal Disorders
Current Drug Metabolism Targeting the Cholinergic System for Neuroprotection and/or Enhancement of Functional Recovery Following Neurotrauma
Current Pharmaceutical Design Gene Therapy: Optimising DNA Delivery to the Nucleus
Current Drug Targets Molecular and Genetic Mechanisms of Osteoporosis: Implication for Treatment
Current Molecular Medicine Physical Activity Interferes with the Immunomodulatory Effect of the Antineoplastic Drug NSC631570
Current Pharmaceutical Biotechnology Immunometabolism in the Pathogenesis of Depressive Disorders - Therapeutic Considerations
Current Topics in Medicinal Chemistry